Coronary Artery Disease (CAD) MortalityNCT06506383
Coronary Artery Disease Mortality in Turkiye
An observational study of Coronary Artery Disease (CAD) Mortality, run by Medipol University at 1 site in Turkey (Türkiye).
Trial summary
This study aims to analyze the geographical variations and identify key environmental and behavioral predictors of coronary artery disease (CAD) mortality in Turkiye. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Coronary Artery Disease (CAD) Mortality
- How many people
- 81 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jan 2020to 30 Jun 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: The study population includes all citizens in each of the 81 provinces of Turkiye
Who may be able to join
- All citizens in a given province
Who cannot join
- None
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Istanbul Medipol University
Beykoz, Istanbul, 34810
About this study
Official title: Geographical Variations and Predictors of Coronary Artery Disease Mortality in Turkiye: An Environmental and Behavioral Analysis
This study aims to analyze the geographical variations and identify key environmental and behavioral predictors of coronary artery disease (CAD) mortality in Turkiye.
Read the detailed description
A 10-year longitudinal province-level data was used to identify change trajectories of CAD mortality. . Environmental determinants (such as air quality and climatic conditions) and behavioral factors of alcohol consumption and smoking were examined for their association with CAD mortality change trajectories using Ordinal Logistic Regression models.
- Conditions
- Coronary Artery Disease (CAD) Mortality
- Being tested
- No Intervention as this is an ecological study
- Medical subject headings
- Coronary Artery Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No Intervention as this is an ecological studyOther
No Intervention as this is an ecological study
What is being measured
The primary outcome is the main question the study is designed to answer.
CAD Mortality
coronary artery disease (CAD) mortality per 100,000 population
Measured: 2010-2019
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2024
- Study start1 Jan 2020
- Primary completion31 Dec 2022
- Study completion30 Jun 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Coronary Artery Disease (CAD) MortalityStudies of the same condition, open and under way.
- More trials run by Medipol UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Retrospective
- Enrolment
- 81 participants (actual)
Sponsor and investigators
- Lead sponsor
- Medipol University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mehmet Kocak, Medipol University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06506383
- Sponsor's protocol ID
- CAD001
- Status last verified
- Jul 2024
- First submitted
- 11 Jul 2024
- Last updated
- 17 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: These are national mortality data and we cannot share it
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Geographical Variations and Predictors of Coronary Artery Disease Mortality in Turkiye: An Environmental and Behavioral Analysis
- ClinicalTrials.gov ID
- NCT06506383
- Acronym / sponsor ID
- CAD001
- Conditions
- Coronary Artery Disease (CAD) Mortality
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 81 participants (actual)
- Lead sponsor
- Medipol UniversityUniversity, hospital or other
- Study start
- 1 Jan 2020 (actual)
- Primary completion
- 31 Dec 2022 (actual)
- Study completion
- 30 Jun 2023 (actual)
- First posted
- 17 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to analyze the geographical variations and identify key environmental and behavioral predictors of coronary artery disease (CAD) mortality in Turkiye.
Detailed description
A 10-year longitudinal province-level data was used to identify change trajectories of CAD mortality. . Environmental determinants (such as air quality and climatic conditions) and behavioral factors of alcohol consumption and smoking were examined for their association with CAD mortality change trajectories using Ordinal Logistic Regression models.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The study population includes all citizens in each of the 81 provinces of Turkiye
Key inclusion criteria (1 listed)
- All citizens in a given province
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No Intervention as this is an ecological studyNo Intervention as this is an ecological study | Other | – |
Primary outcome
CAD Mortality
Time frame: 2010-2019
coronary artery disease (CAD) mortality per 100,000 population
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2024.
- Individual participant dataSharing planned: No. These are national mortality data and we cannot share it
Related trials for Coronary Artery Disease (CAD) Mortality
Not yet recruitingObservational study
Assessment of Transnational Performance of the Universal Cardiac Surgical Risk Score Across International Sites
Heart Valve Diseases, Cardiac Surgical Procedures
Not yet recruitingObservational study
Clinical Evidence With Biomarker Confirmation for PPMI in PCI Clinical Trials Study
Peri-procedural Myocardial Infarction, Heart Failure Hospitalization
Not yet recruiting
A Cluster-Randomized Controlled Trial
Hypertension, Stroke
RecruitingObservational study
Procedural Complications and Long-Term Mortality in Complex Coronary Interventions
Complex Coronary Artery Disease
Recruiting
Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease
Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Coronary Artery Disease (CAD) Mortality, run by Medipol University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
CAD Mortality (time frame: 2010-2019). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2024.